Menopause
Surgical Techniques
Tissue extraction at minimally invasive surgery: Where do we go from here?
Open power morcellation now is contraindicated in perimenopausal and postmenopausal women. What is Johns Hopkins’ protocol in this new climate? An...
News for Your Practice
Vasomotor symptoms of menopause often persist longer than 7 years
New data from the SWAN study reveal that African American women have the longest median duration of vasomotor symptoms, at 10.1 years, and...
Expert Commentary
Dr. Andrew M. Kaunitz on prescribing systemic HT to older women
Prescribing systemic hormone therapy is common, but controversial. Dr. Kaunitz elaborates on specific dosing and tapering patients, as well as...
News
Seven years of hot flashes common during, after menopause
Key clinical point: Vasomotor symptoms persist for more years and last longer past menopause than previously known. Major finding: Women...
News
Short-term hormone replacement therapy upped ovarian cancer risk
Key clinical point: Hormone replacement therapy (HRT) was linked to an increased risk of ovarian cancer. Major finding: Current use of HRT for...
News
Unnecessary hysterectomies still significant, Michigan data indicate
Key clinical point: Take the time to try levonorgestrel IUDs and other alternatives before removing a woman’s uterus. Major finding: About 40% of...
News
Hot flashes linked to increased hip fracture risk
Key clinical point: The severity of vasomotor menopause symptoms is associated with risk of hip fracture. Major finding: Women with moderate to...
News
Hormone therapy ‘timing hypothesis’ gains ground in ELITE
Key clinical point: Hormone therapy cut atherosclerotic progression, compared with placebo, in women 6 or fewer years out from menopause start,...
News
Osteoporosis medication use down in older women
News
New use for old DXA scanners?
Key clinical point: Dual energy X-ray absorptiometry (DXA) data may be better than BMI for assessing metabolic health in postmenopausal women,...
Clinical Review
2014 Update on osteoporosis
A new agent, and new understandings of old drugs, top the year’s developments in bone health